Oral SERDs in Breast Cancer: Imulnestrant and Elacestrant
Oral selective estrogen receptor degraders (SERDs) are a promising line of treatments for patients with breast cancer.
FDA Approves Updated COVID-19 Vaccines Targeting LP.8.1 For Older Adults, Those At-Risk
The FDA’s approvals follows new COVID-19 guidance announced by the commissioner of the agency in May 2025, focusing future approvals…
Orforglipron’s Success in Phase 3 Trial Triggers Regulatory Submissions for Obesity Treatment
Orforglipron is an effective treatment, leading to significant body weight reduction and improved glycemic control.
Neighborhood Marginalization Worsens Outcomes in Young Myocardial Infarction Survivors
Young adults who had experienced an acute myocardial infarction and lived in marginalized communities had increased risks of adverse events…
FDA Grants I-DXd Breakthrough Therapy Designation in Treatment of ES-SCLC
The action is significant for patients with extensive-stage small cell lung cancer (SCLC), a population with limited treatment options.
Peggy Lillis Foundation to Host 16th Annual “Changing the Odds Gala” to Raise critical Funds for C. Difficile Advocacy
The event will also recognize patient advocates and medical leaders making a difference in the fight against of the nation’s…
A High-Performance Room-Temperature Acetone Gas Sensor Could Aid Diabetes Detection
The sensor detects acetone levels in the breath to indicate diabetes.
Common Cold Linked to Reduced Risk of COVID-19 Infection
Rhinovirus infection, which causes the common cold, could offer infected children more respiratory pathway protection from SARS-CoV-2 infection.